Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
04 12 2019
Historique:
received: 01 02 2019
revised: 15 07 2019
accepted: 07 11 2019
entrez: 6 12 2019
pubmed: 6 12 2019
medline: 12 9 2020
Statut: ppublish

Résumé

Aging involves a decline in neural function that contributes to cognitive impairment and disease. However, the mechanisms underlying the transition from a young-and-healthy to aged-and-dysfunctional brain are not well understood. Here, we report breakdown of the vascular blood-brain barrier (BBB) in aging humans and rodents, which begins as early as middle age and progresses to the end of the life span. Gain-of-function and loss-of-function manipulations show that this BBB dysfunction triggers hyperactivation of transforming growth factor-β (TGFβ) signaling in astrocytes, which is necessary and sufficient to cause neural dysfunction and age-related pathology in rodents. Specifically, infusion of the serum protein albumin into the young rodent brain (mimicking BBB leakiness) induced astrocytic TGFβ signaling and an aged brain phenotype including aberrant electrocorticographic activity, vulnerability to seizures, and cognitive impairment. Furthermore, conditional genetic knockdown of astrocytic TGFβ receptors or pharmacological inhibition of TGFβ signaling reversed these symptomatic outcomes in aged mice. Last, we found that this same signaling pathway is activated in aging human subjects with BBB dysfunction. Our study identifies dysfunction in the neurovascular unit as one of the earliest triggers of neurological aging and demonstrates that the aging brain may retain considerable latent capacity, which can be revitalized by therapeutic inhibition of TGFβ signaling.

Identifiants

pubmed: 31801886
pii: 11/521/eaaw8283
doi: 10.1126/scitranslmed.aaw8283
pii:
doi:

Substances chimiques

Albumins 0
Protein Kinase Inhibitors 0
Transforming Growth Factor beta 0
Receptor, Transforming Growth Factor-beta Type I EC 2.7.11.30

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS066005
Pays : United States
Organisme : NINDS NIH HHS
ID : R56 NS066005
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG042679
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG054147
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Vladimir V Senatorov (VV)

Helen Wills Neuroscience Institute and Berkeley Stem Cell Center, University of California, Berkeley, Berkeley, CA 94720, USA.
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Aaron R Friedman (AR)

Helen Wills Neuroscience Institute and Berkeley Stem Cell Center, University of California, Berkeley, Berkeley, CA 94720, USA.
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Dan Z Milikovsky (DZ)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Jonathan Ofer (J)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Rotem Saar-Ashkenazy (R)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Adiel Charbash (A)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Naznin Jahan (N)

Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Gregory Chin (G)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Eszter Mihaly (E)

Department of Bioengineering, University of California, Berkeley, Berkeley, CA 94720, USA.

Jessica M Lin (JM)

Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Harrison J Ramsay (HJ)

Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Ariana Moghbel (A)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Marcela K Preininger (MK)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Chelsy R Eddings (CR)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Helen V Harrison (HV)

School of Public Health, University of California, Berkeley, Berkeley, CA 94720, USA.

Rishi Patel (R)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Yishuo Shen (Y)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Hana Ghanim (H)

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Huanjie Sheng (H)

Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Ronel Veksler (R)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Peter H Sudmant (PH)

Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Albert Becker (A)

Section for Translational Epilepsy Research, Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany.

Barry Hart (B)

Innovation Pathways, Palo Alto, CA 94301, USA.

Michael A Rogawski (MA)

Department of Neurology, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA.

Andrew Dillin (A)

Glenn Center for Aging Research, Howard Hughes Medical Institute, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Alon Friedman (A)

Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Department of Medical Neuroscience and Brain Repair Center, Dalhousie University, Halifax, NS B3H4R2, Canada.

Daniela Kaufer (D)

Helen Wills Neuroscience Institute and Berkeley Stem Cell Center, University of California, Berkeley, Berkeley, CA 94720, USA. danielak@berkeley.edu.
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Canadian Institute for Advanced Research, Toronto, ON M5G1M1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH